article thumbnail

Celebrating Black History Month: Black Scientists that Have Revolutionized the Life Sciences

XTalks

In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. This invention made it possible to remove cataracts more safely and quickly, significantly improving vision restoration techniques.

article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Consumers want convenient, online doctor-finding tools

pharmaphorum

When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients. That number is up 17% from 2019.

Doctors 98
article thumbnail

New Trivalent Flu Vaccine for 2024/2025 and Other Insights from Leading Infectious Disease Experts Dr. Willliam Schaffner and Dr. Kelly Moore

XTalks

Influenza viruses are highly mutable, which necessitates continuous monitoring and adjustments in vaccine formulations. These seasonal outbreaks can vary in severity, depending on the circulating strains of the virus and public health preparedness, including vaccination coverage and effectiveness.

article thumbnail

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

pharmaphorum

B was founded in 2021 to connect providers with leftover COVID vaccines to the patients seeking to receive them. Our doctor consultations only cost $15, less than the average insurance copay. at the height of the COVID crisis to save lives by getting vaccines to people who needed them.

article thumbnail

GSK’s Vaccine Awareness Campaign Targets Baby Boomers

XTalks

It’s hard enough to get older adults to get routine vaccines but during a global pandemic, it’s nearly impossible. That’s why GlaxoSmithKline (GSK) has launched a disease awareness campaign — called “ Brought to You By Vaccines ” — to help those ages 50 and older identify gaps in their own immunity against vaccine-preventable diseases.

article thumbnail

GSK’s Arexvy Leads Over Pfizer’s Abrysvo in Year One of RSV Vaccine Market Battle

XTalks

In the first year of the respiratory syncytial virus (RSV) vaccine battle, GlaxoSmithKline’s (GSK) Arexvy emerged as the winner over Pfizer’s Abrysvo. Going up against vaccine stalwart Pfizer wasn’t an easy feat but GSK succeeded in the challenge by taking an early lead in the RSV vaccine battle. billion or £1.2